Pharmacophore Modelling and 3D-QSAR Studies on <svg style="vertical-align:-0.19798pt;width:24.775px;" id="M1" height="20.137501" version="1.1" viewBox="0 0 24.775 20.137501" width="24.775"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,20.1375)">
		<g transform="translate(72,-55.89)">
			<text transform="matrix(1,0,0,-1,-71.95,56.14)">
				<tspan style="font-size: 17.93px; " x="0" y="0">N</tspan>
			</text>

			<text transform="matrix(1,0,0,-1,-59,63.31)">
				<tspan style="font-size: 12.55px; " x="0" y="0">𝟑</tspan>
			</text>

		</g>
	</g>
</svg>-Phenylpyrazinones as Corticotropin-Releasing Factor 1 Receptor Antagonists

<table>Best pharmacophore model AADHHR.47 aligned with molecule 48. Pharmacophore features are color coded: 2 hydrogen bond acceptors (A2, A4; pink), 1 hydrogen bond donor (D6; blue), 2 hydrophobic regions (H10, H11; green), and 1 aromatic ring (R12; orange).</table>

International Journal of Medicinal Chemistry

fig3

Figure 3

Figure 3: Pharmacophore Modelling and 3D-QSAR Studies on <svg style="vertical-align:-0.19798pt;width:24.775px;" id="M1" height="20.137501" version="1.1" viewBox="0 0 24.775 20.137501" width="24.775"  xmlns="http://www.w3.org/2000/svg">
	<g transform="matrix(1.25,0,0,-1.25,0,20.1375)">
		<g transform="translate(72,-55.89)">
			<text transform="matrix(1,0,0,-1,-71.95,56.14)">
				<tspan style="font-size: 17.93px; " x="0" y="0">N</tspan>
			</text>

			<text transform="matrix(1,0,0,-1,-59,63.31)">
				<tspan style="font-size: 12.55px; " x="0" y="0">𝟑</tspan>
			</text>

		</g>
	</g>
</svg>-Phenylpyrazinones as Corticotropin-Releasing Factor 1 Receptor Antagonists 

Figure 3 | Pharmacophore Modelling and 3D-QSAR Studies on 
	
		
			
				N
			

			
				𝟑
			

		
	
-Phenylpyrazinones as Corticotropin-Releasing Factor 1 Receptor Antagonists 

International Journal of Medicinal Chemistry

Pharmacophore Modelling and 3D-QSAR Studies on N 𝟑 -Phenylpyrazinones as Corticotropin-Releasing Factor 1 Receptor Antagonists

Figure 3

Pharmacophore Modelling and 3D-QSAR Studies on -Phenylpyrazinones as Corticotropin-Releasing Factor 1 Receptor Antagonists